RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications
2019-01-01 Saeed, O.; Lopez-Beltran, A.; Fisher, K. W.; Scarpelli, M.; Montironi, R.; Cimadamore, A.; Massari, F.; Santoni, M.; Cheng, L.
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
2020-01-01 Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Aurilio, G.; Santoni, M.; Massari, F.; Cheng, L.
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments
2021-01-01 Santoni, M.; Tombesi, F.; Cimadamore, A.; Montironi, R.; Piva, F.
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives
2020-01-01 Zong, Y.; Montironi, R.; Massari, F.; Jiang, Z.; Lopez-Beltran, A.; Wheeler, T. M.; Scarpelli, M.; Santoni, M.; Cimadamore, A.; Cheng, L.
Emerging molecular technologies in renal cell carcinoma: Liquid biopsy
2019-01-01 Cimadamore, A.; Gasparrini, S.; Massari, F.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.
Whole slide imaging of large format histology in prostate pathology: Potential for information fusion
2017-01-01 Montironi, Rodolfo; Cimadamore, Alessia; Massari, Francesco; Montironi, Maria Alessandra; Lopez-Beltran, Antonio; Cheng, Liang; Montorsi, Francesco; Scarpelli, Marina
Circulating tumor dna testing for homology recombination repair genes in prostate cancer: From the lab to the clinic
2021-01-01 Cimadamore, A.; Cheng, L.; Massari, F.; Santoni, M.; Pepi, L.; Franzese, C.; Scarpelli, M.; Lopez-Beltran, A.; Galosi, A. B.; Montironi, R.
Liquid biopsy in the clinical management of bladder cancer: current status and future developments
2020-01-01 Kouba, E.; Lopez-Beltran, A.; Montironi, R.; Massari, F.; Huang, K.; Santoni, M.; Chovanec, M.; Cheng, M.; Scarpelli, M.; Zhang, J.; Cimadamore, A.; Cheng, L.
Immunotherapy in genitourinary cancers: Where are we going?
2017-01-01 Bianconi, M.; Faloppi, L.; Lopez-Beltran, A.; Cheng, L.; Cimadamore, A.; Gasparrini, S.; Massari, F.; Scarpelli, M.; Montironi, R.
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer
2019-01-01 Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A.
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications
2020-01-01 Occhipinti, G.; Romagnoli, E.; Santoni, M.; Cimadamore, A.; Sorgentoni, G.; Cecati, M.; Giulietti, M.; Battelli, N.; Maccioni, A.; Storti, N.; Cheng, L.; Principato, G.; Montironi, R.; Piva, F.
Pd-l1 testing for urothelial carcinoma: Interchangeability, reliability and future perspectives
2021-01-01 Gevaert, T.; Cimadamore, A.; Montironi, R.; Eckstein, M.
Epigenetic modulations and lineage plasticity in advanced prostate cancer
2020-01-01 Ge, R.; Wang, Z.; Montironi, R.; Jiang, Z.; Cheng, M.; Santoni, M.; Huang, K.; Massari, F.; Lu, X.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
2018-01-01 Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A.
Pd-l1 inhibitors for the treatment of prostate cancer
2020-01-01 Santoni, M.; Massari, F.; Cheng, L.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Lopez-Beltran, A.
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
2019-01-01 Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
The coronavirus disease 2019 (COVID-19) pandemic’s impact on social interaction in pathology
2021-01-01 Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.
Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique
2021-01-01 Rocco, B.; Sarchi, L.; Assumma, S.; Cimadamore, A.; Montironi, R.; Reggiani Bonetti, L.; Turri, F.; De Carne, C.; Puliatti, S.; Maiorana, A.; Pellacani, G.; Micali, S.; Bianchi, G.; Sighinolfi, M. C.
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory?
2021-01-01 Marchetti, A.; Rosellini, M.; Mollica, V.; Rizzo, A.; Tassinari, E.; Nuvola, G.; Cimadamore, A.; Santoni, M.; Fiorentino, M.; Montironi, R.; Massari, F.
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
2022-01-01 Stangl-Kremser, J.; Muto, G.; Grosso, A. A.; Briganti, A.; Comperat, E.; Maida, F. D.; Montironi, R.; Remzi, M.; Pradere, B.; Soria, F.; Albisinni, S.; Roupret, M.; Shariat, S. F.; Minervini, A.; Teoh, J. Y. -C.; Moschini, M.; Cimadamore, A.; Mari, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications | 1-gen-2019 | Saeed, O.; Lopez-Beltran, A.; Fisher, K. W.; Scarpelli, M.; Montironi, R.; Cimadamore, A.; Massari, F.; Santoni, M.; Cheng, L. | |
| Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer | 1-gen-2020 | Montironi, R.; Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Aurilio, G.; Santoni, M.; Massari, F.; Cheng, L. | |
| Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments | 1-gen-2021 | Santoni, M.; Tombesi, F.; Cimadamore, A.; Montironi, R.; Piva, F. | |
| Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives | 1-gen-2020 | Zong, Y.; Montironi, R.; Massari, F.; Jiang, Z.; Lopez-Beltran, A.; Wheeler, T. M.; Scarpelli, M.; Santoni, M.; Cimadamore, A.; Cheng, L. | |
| Emerging molecular technologies in renal cell carcinoma: Liquid biopsy | 1-gen-2019 | Cimadamore, A.; Gasparrini, S.; Massari, F.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R. | |
| Whole slide imaging of large format histology in prostate pathology: Potential for information fusion | 1-gen-2017 | Montironi, Rodolfo; Cimadamore, Alessia; Massari, Francesco; Montironi, Maria Alessandra; Lopez-Beltran, Antonio; Cheng, Liang; Montorsi, Francesco; Scarpelli, Marina | |
| Circulating tumor dna testing for homology recombination repair genes in prostate cancer: From the lab to the clinic | 1-gen-2021 | Cimadamore, A.; Cheng, L.; Massari, F.; Santoni, M.; Pepi, L.; Franzese, C.; Scarpelli, M.; Lopez-Beltran, A.; Galosi, A. B.; Montironi, R. | |
| Liquid biopsy in the clinical management of bladder cancer: current status and future developments | 1-gen-2020 | Kouba, E.; Lopez-Beltran, A.; Montironi, R.; Massari, F.; Huang, K.; Santoni, M.; Chovanec, M.; Cheng, M.; Scarpelli, M.; Zhang, J.; Cimadamore, A.; Cheng, L. | |
| Immunotherapy in genitourinary cancers: Where are we going? | 1-gen-2017 | Bianconi, M.; Faloppi, L.; Lopez-Beltran, A.; Cheng, L.; Cimadamore, A.; Gasparrini, S.; Massari, F.; Scarpelli, M.; Montironi, R. | |
| Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer | 1-gen-2019 | Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A. | |
| Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications | 1-gen-2020 | Occhipinti, G.; Romagnoli, E.; Santoni, M.; Cimadamore, A.; Sorgentoni, G.; Cecati, M.; Giulietti, M.; Battelli, N.; Maccioni, A.; Storti, N.; Cheng, L.; Principato, G.; Montironi, R.; Piva, F. | |
| Pd-l1 testing for urothelial carcinoma: Interchangeability, reliability and future perspectives | 1-gen-2021 | Gevaert, T.; Cimadamore, A.; Montironi, R.; Eckstein, M. | |
| Epigenetic modulations and lineage plasticity in advanced prostate cancer | 1-gen-2020 | Ge, R.; Wang, Z.; Montironi, R.; Jiang, Z.; Cheng, M.; Santoni, M.; Huang, K.; Massari, F.; Lu, X.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L. | |
| Immunotherapy in renal cell carcinoma: latest evidence and clinical implications | 1-gen-2018 | Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A. | |
| Pd-l1 inhibitors for the treatment of prostate cancer | 1-gen-2020 | Santoni, M.; Massari, F.; Cheng, L.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Lopez-Beltran, A. | |
| Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians | 1-gen-2019 | Gasparrini, S.; Cimadamore, A.; Scarpelli, M.; Massari, F.; Doria, A.; Mazzucchelli, R.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| The coronavirus disease 2019 (COVID-19) pandemic’s impact on social interaction in pathology | 1-gen-2021 | Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M. | |
| Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique | 1-gen-2021 | Rocco, B.; Sarchi, L.; Assumma, S.; Cimadamore, A.; Montironi, R.; Reggiani Bonetti, L.; Turri, F.; De Carne, C.; Puliatti, S.; Maiorana, A.; Pellacani, G.; Micali, S.; Bianchi, G.; Sighinolfi, M. C. | |
| The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? | 1-gen-2021 | Marchetti, A.; Rosellini, M.; Mollica, V.; Rizzo, A.; Tassinari, E.; Nuvola, G.; Cimadamore, A.; Santoni, M.; Fiorentino, M.; Montironi, R.; Massari, F. | |
| The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis | 1-gen-2022 | Stangl-Kremser, J.; Muto, G.; Grosso, A. A.; Briganti, A.; Comperat, E.; Maida, F. D.; Montironi, R.; Remzi, M.; Pradere, B.; Soria, F.; Albisinni, S.; Roupret, M.; Shariat, S. F.; Minervini, A.; Teoh, J. Y. -C.; Moschini, M.; Cimadamore, A.; Mari, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista47361
- 2 Contributo in Volume1
- 3 Libro1
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713529
- 2010 - 201915290
- 2000 - 200910529
- 1990 - 19995844
- 1980 - 19891783
- 1970 - 1979315
- 1960 - 196935
Editore
- Elsevier BV:PO Box 211, 1000 AE A...288
- American Institute of Physics:2 H...269
- Germany: Springer Verlag Germany101
- Elsevier Science Limited:Oxford F...71
- Elsevier Science Incorporated / N...60
- Springer Verlag Germany:Tiergarte...57
- Taylor & Francis Limited:Rankine ...56
- Edizioni Minerva Medica:Corso Bra...52
- S Karger AG:Allschwilerstrasse 10...48
- Annals Publishing Company:4507 La...47
Rivista
- PHYSICAL REVIEW LETTERS520
- PHYSICS LETTERS. SECTION B491
- THE EUROPEAN PHYSICAL JOURNAL. C,...451
- JOURNAL OF HIGH ENERGY PHYSICS351
- PHYSICAL REVIEW D, PARTICLES, FIE...305
- NUCLEAR INSTRUMENTS & METHODS IN ...202
- PHYSICAL REVIEW D157
- THE ASTROPHYSICAL JOURNAL156
- PLOS ONE149
- SCIENTIFIC REPORTS133
Serie
- REGIONAL DOSSIERS SERIES1
Keyword
- Humans1080
- Female609
- Male544
- Middle Aged356
- Italy330
- Adult316
- COVID-19313
- Medicine (all)282
- Aged281
- Biochemistry192
Lingua
- eng30123
- ita9631
- fre359
- spa205
- ger192
- rus48
- fur28
- und27
- lat25
- pol25
Accesso al fulltext
- no fulltext32299
- open8479
- reserved6158
- partially open395
- restricted18
- embargoed10
- mixed3